Ozaki A, Yoneda M, Kessoku T et al (2020) Effect of tofogliflozin and pioglitazone on hepatic steatosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A randomized, open-label pilot study (ToPiND study)
A recent narrative review in the Journal of Clinical Endocrinology & Metabolism warns that these drugs may also significantly reduce muscle mass, potentially compromising long-term fitness and mobility, particularly in older adults
Even minor manufacturing variations can influence impurity profiles, molecular stability, and potential immunogenicity
Semaglutide 2.4 mg (Wegovy, FDA-approved for weight management) reports diarrhea in approximately 30% of patients in clinical trials according to the FDA prescribing information
Not applying sunscreen on smaller areas: Harmful UV rays spare nothing, no exceptions
This guide covers our Lemon Bottle fat dissolving treatment for the submental area, the small fat pad under the chin that diet and exercise often leave untouched